Varian Medical Systems

Company Medical Device

Varian Medical Systems Secures NMPA Approval for Ethos 2.0 AI Radiotherapy Platform

Fineline Cube Jun 12, 2025

US-based Varian Medical Systems (NYSE: VAR) announced that it has received marketing approval from China’s...

Company Medical Device

Varian Medical Gets China Approval for Fourth-Generation Halcyon Radiotherapy System

Fineline Cube Jun 4, 2024

Varian Medical Systems (NYSE: VAR), a US-based leader in cancer treatment technology, has announced that...

Company Drug

Sino Biopharm’s TQA3605 Meets Endpoint in Hepatitis B Phase II Trial

Company Drug

J&J Darzalex Faspro Gets FDA Nod for NDMM D-VRd Regimen

Company Drug

Roche CT-388 Obesity Drug Shows 22.5% Weight Loss in Phase II Trial

Policy / Regulatory

FDA Removes Suicide Warnings from GLP‑1 Drugs After Investigation Finds No Causal Link